MarketPulse

Wegovy HD

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Novo Nordisk

Novo Nordisk Raises 2026 Outlook as Wegovy® Pills Exceed 2M Prescriptions

Novo Nordisk reported Q1 2026 adjusted operating profit of DKK 32.9B, raising 2026 guidance on Wegovy® pill's success with 2M total prescriptions since January launch.
NVOFDA approvalguidance raise
BenzingaBenzinga··Vandana Singh

GoodRx Surges on Wegovy HD Expansion, Tapping $399/Month Self-Pay Obesity Market

GoodRx shares rose 2.69% as the platform expands access to Novo Nordisk's Wegovy HD at $399/month, capitalizing on the surging self-pay GLP-1 obesity treatment market.
LLYNVOGDRXobesity treatmentGLP-1 treatments
BenzingaBenzinga··Vandana Singh

Novo Nordisk Wins FDA Nod for High-Dose Wegovy, Expanding GLP-1 Arsenal

Novo Nordisk wins FDA approval for Wegovy HD, a higher-dose version launching in April across 70,000+ U.S. pharmacies, despite modest stock decline.
NVOHIMSFDA approvalclinical trial